Bayer to buy Chinese OTC company Dihon

28 February 2014 - Deborah Wilkes

Archived

Bayer is strengthening its Consumer Care business in China and gaining a foothold in Traditional Chinese Medicine (TCM) by acquiring Dihon Pharmaceutical for an undisclosed sum.

Click tags below for more information on topics:

TCM

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: